Copyright
©The Author(s) 2021.
World J Gastroenterol. Mar 14, 2021; 27(10): 939-958
Published online Mar 14, 2021. doi: 10.3748/wjg.v27.i10.939
Published online Mar 14, 2021. doi: 10.3748/wjg.v27.i10.939
Figure 6 Huanglian decoction suppressed hepatocellular carcinoma cell growth in vitro.
A: Time- and dose-dependent effects of Huanglian decoction treatment on the viability of both PLC/PRF/5 and HepG2 cells; B: Huanglian decoction can induce apoptosis of both PLC/PRF/5 and HepG2 cells; C: Huanglian decoction can reduce the migration activity of both PLC/PRF/5 and HepG2 cells; D: Huanglian decoction can reduce the invasion activity of both PLC/PRF/5 and HepG2 cells. aP < 0.05 vs negative control (NC) group; bP < 0.01 vs NC group; cP < 0.001 vs NC group. FITC: Fluorescein isothiocyanate.
- Citation: Li M, Shang H, Wang T, Yang SQ, Li L. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing CCNB1 expression. World J Gastroenterol 2021; 27(10): 939-958
- URL: https://www.wjgnet.com/1007-9327/full/v27/i10/939.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i10.939